{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T05:59:59Z","timestamp":1777183199557,"version":"3.51.4"},"reference-count":21,"publisher":"Japanese Society of Internal Medicine","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026,1,1]]},"DOI":"10.2169\/internalmedicine.5585-25","type":"journal-article","created":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T18:07:34Z","timestamp":1749665254000},"page":"178-182","source":"Crossref","is-referenced-by-count":1,"title":["M232R Familial Creutzfeldt-Jacob Disease Challenging to Diagnose Due to the Absence of Characteristic Laboratory Findings"],"prefix":"10.2169","volume":"65","author":[{"given":"Yoshiko","family":"Tanaka","sequence":"first","affiliation":[{"name":"Division of Respirology, Neurology and Rheumatology, Department of Medicine, Kurume University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken-Ichi","family":"Irie","sequence":"additional","affiliation":[{"name":"Division of Respirology, Neurology and Rheumatology, Department of Medicine, Kurume University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashige","family":"Isogai","sequence":"additional","affiliation":[{"name":"Division of Respirology, Neurology and Rheumatology, Department of Medicine, Kurume University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamon","family":"Koga","sequence":"additional","affiliation":[{"name":"Division of Respirology, Neurology and Rheumatology, Department of Medicine, Kurume University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichiro","family":"Mori","sequence":"additional","affiliation":[{"name":"Division of Respirology, Neurology and Rheumatology, Department of Medicine, Kurume University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahisa","family":"Tateishi","sequence":"additional","affiliation":[{"name":"Division of Respirology, Neurology and Rheumatology, Department of Medicine, Kurume University School of Medicine, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Kupfer L, Hinrichs W, Groschup MH. Prion protein misfolding. Curr Mol Med 9: 826-835, 2009.","DOI":"10.2174\/156652409789105543"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Kang YJ, Kim KH, Jang SH, et al. Diffusion-weighted imaging negative M232R familial Creutzfeldt-Jakob disease. J Clin Neurosci 64: 47-49, 2019.","DOI":"10.1016\/j.jocn.2019.03.019"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Johnson RT. Prion diseases. Lancet Neurol 4: 635-642, 2005.","DOI":"10.1016\/S1474-4422(05)70192-7"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Nozaki I, Hamaguchi T, Sanjo N, et al. Prospective 10-year surveillance of human prion diseases in Japan. Brain 133: 3043-3057, 2010.","DOI":"10.1093\/brain\/awq216"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Shiga Y, Satoh K, Kitamoto T, et al. Two different clinical phenotypes of Creutzfeldt-Jakob disease with a M232R substitution. J Neurol 254: 1509-1517, 2007.","DOI":"10.1007\/s00415-007-0540-9"},{"key":"6","doi-asserted-by":"publisher","unstructured":"6. Vitali P, Maccagnano E, Caverzasi E, et al. Diffusion-weighted MRI hyperintensity patterns differentiate CJD from other rapid dementias. Neurology 76: 1711-1719, 2011.","DOI":"10.1212\/WNL.0b013e31821a4439"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Parchi P, Giese A, Capellari S, et al. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 46: 224-233, 1999.","DOI":"10.1002\/1531-8249(199908)46:2<224::AID-ANA12>3.0.CO;2-W"},{"key":"8","doi-asserted-by":"publisher","unstructured":"8. Jin K, Shiga Y, Shibuya S, et al. Clinical features of Creutzfeldt-Jakob disease with V180I mutation. Neurology 62: 502-505, 2004.","DOI":"10.1212\/01.WNL.0000106954.54011.80"},{"key":"9","doi-asserted-by":"publisher","unstructured":"9. Arata H, Takashima H, Hirano R, et al. Early clinical signs and imaging findings in Gerstmann-Str\u00e4ussler-Scheinker syndrome (Pro102Leu). Neurology 66: 1672-1678, 2006.","DOI":"10.1212\/01.wnl.0000218211.85675.18"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Gao LP, Shi Q, Xiao K, et al. The genetic Creutzfeldt-Jakob disease with E200K mutation: analysis of clinical, genetic and laboratory features of 30 Chinese patients. Sci Rep 9: 1836, 2019.","DOI":"10.1038\/s41598-019-38520-y"},{"key":"11","unstructured":"11. Young GS, Geschwind MD, Fischbein NJ, et al. Diffusion-weighted and fluid-attenuated inversion recovery imaging in Creutzfeldt-Jakob disease: high sensitivity and specificity for diagnosis. AJNR Am J Neuroradiol 26: 1551-1562, 2005."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Koide T, Ohtake H, Nakajima T, et al. A patient with dementia with Lewy bodies and codon 232 mutation of <i>PRNP<\/i>. Neurology 59: 1619-1621, 2002.","DOI":"10.1212\/01.WNL.0000033796.33205.B4"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Borsook D. Neurological diseases and pain. Brain 135 (Pt 2): 320-344, 2012.","DOI":"10.1093\/brain\/awr271"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Beck J, Collinge J, Mead S. Prion protein gene <i>M232R<\/i> variation is probably an uncommon polymorphism rather than a pathogenic mutation. Brain 135 (Pt 2): e209; author reply e210, 2012.","DOI":"10.1093\/brain\/awr294"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Gu Y, Singh A, Bose S, Singh N. Pathogenic mutations in the glycosylphosphatidylinositol signal peptide of PrP modulate its topology in neuroblastoma cells. Mol Cell Neurosci 37: 647-656, 2008.","DOI":"10.1016\/j.mcn.2007.08.018"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Kobayashi A, Hirata T, Shimazaki T, et al. A point mutation in GPI-attachment signal peptide accelerates the development of prion disease. Acta Neuropathol 145: 637-650, 2023.","DOI":"10.1007\/s00401-023-02553-5"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Kon T, Miki Y, Arai A, et al. Creutzfeldt-Jakob disease with homozygous M232R mutation: a case report. J Neurol Sci 352 (1-2): 108-109, 2015.","DOI":"10.1016\/j.jns.2015.03.017"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Stoeck K, Sanchez-Juan P, Gawinecka J, et al. Cerebrospinal fluid biomarker supported diagnosis of Creutzfeldt-Jakob disease and rapid dementias: a longitudinal multicentre study over 10 years. Brain 135 (Pt 10): 3051-3061, 2012.","DOI":"10.1093\/brain\/aws238"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Hermann P, Appleby B, Brandel JP, et al. Biomarkers and diagnostic guidelines for sporadic Creutzfeldt-Jakob disease. Lancet Neurol 20: 235-246, 2021.","DOI":"10.1016\/S1474-4422(20)30477-4"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Steinhoff BJ, R\u00e4cker S, Herrendorf G, et al. Accuracy and reliability of periodic sharp wave complexes in Creutzfeldt-Jakob disease. Arch Neurol 53: 162-166, 1996.","DOI":"10.1001\/archneur.1996.00550020074017"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Atarashi R, Satoh K, Sano K, et al. Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking-induced conversion. Nat Med 17: 175-178, 2011.","DOI":"10.1038\/nm.2294"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/1\/65_5585-25\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,3]],"date-time":"2026-01-03T03:26:41Z","timestamp":1767410801000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/1\/65_5585-25\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,1]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.5585-25","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,1]]},"article-number":"5585-25"}}